XML 30 R21.htm IDEA: XBRL DOCUMENT
v3.22.1

Earnings Per Common Share | 3 Months Ended
--- | ---
Mar. 31, 2022
Earnings Per Share [Abstract] |
Earnings Per Common Share | Earnings per Common Share LCNB has granted restricted stock awards with non-forfeitable dividend rights, which are considered participating securities. Accordingly, earnings per share is computed using the two-class method as required by ASC 260-10-45. Basic earnings per common share is calculated by dividing net income allocated to common shareholders by the weighted average number of common shares outstanding during the period, which excludes the participating securities. Diluted earnings per common share is adjusted for the dilutive effects of stock options, warrants, and restricted stock. The diluted average number of common shares outstanding has been increased for the assumed exercise of stock options and warrants with proceeds used to purchase treasury shares at the average market price for the period. Earnings per share for the three months ended March 31, 2022 and 2021 were calculated as follows (dollars in thousands, except share and per share data):
|  |  | Three Months Ended March 31,
|  |  |  |  | 2022 |  | 2021
Net income |  |  |  |  | $ | 4,523 |  |  | 5,240 |
Less allocation of earnings and dividends to participating securities |  |  |  |  | 24 |  |  | 18 |
Net income allocated to common shareholders |  |  |  |  | $ | 4,499 |  |  | 5,222 |
Weighted average common shares outstanding, gross |  |  |  |  | 11,878,451 |  |  | 12,840,782 |
Less average participating securities |  |  |  |  | 59,837 |  |  | 45,958 |
Weighted average number of shares outstanding used in the calculation of basic earnings per common share |  |  |  |  | 11,818,614 |  |  | 12,794,824 |
Add dilutive effect of: |  |  |  |  |  |  |
Stock options |  |  |  |  | — |  |  | 28 |
Adjusted weighted average number of shares outstanding used in the calculation of diluted earnings per common share |  |  |  |  | 11,818,614 |  |  | 12,794,852 |
Earnings per common share: |  |  |  |  |  |  |
Basic |  |  |  |  | $ | 0.38 |  |  | 0.41 |
Diluted |  |  |  |  | 0.38 |  |  | 0.41 |
There were no anti-dilutive stock options outstanding at March 31, 2022 or 2021.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration